BOSENTAN

Treatment phase: Initial 1 - combination therapy (dual or triple therapy, excluding selexipag) in an untreated patient

Treatment phase: Initial 2 - starting combination therapy (dual or triple therapy, excluding selexipag) in a treated patient where a diagnosis of pulmonary arterial hypertension is established through a prior PBS authority application

Treatment phase: Initial 3 - changing to this drug in combination therapy (dual or triple therapy)

Treatment phase: Continuing treatment of combination therapy (dual or triple therapy, excluding selexipag)

Treatment phase: Triple therapy - Initial treatment or continuing treatment of triple combination therapy (including dual therapy in lieu of triple therapy) that includes selexipag